Vitamin B6 (Pyridoxine)

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.

Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.

Doxylamine Succinate and Pyridoxine Hydrochloride Tablets (10mg/10mg, 20mg/20mg) is the first-line evidence-based pharmacotherapy recommended by ACOG and RCOG for nausea and vomiting of pregnancy (NVP / morning sickness) and hyperemesis gravidarum. Doxylamine is an ethanolamine-derivative H1-antihistamine that competitively blocks H1 and muscarinic receptors in the vestibular system and vomiting center; Pyridoxine (Vitamin B6) acts as a coenzyme in neurotransmitter synthesis, improving metabolic pathways disrupted during early pregnancy.

Thiamine Hydrochloride (100mg), Pyridoxine Hydrochloride (100mg) and Cyanocobalamin (1000mcg) per 3ml Injection is a parenteral neurotropic B-vitamin formulation used for acute neuropathies, severe nutritional deficiency, and Wernicke-Korsakoff syndrome.

Pyridoxine Hydrochloride Tablets (50mg, 100mg, 100mg Sustained Release) is an oral Vitamin B6 formulation on the WHO Model List of Essential Medicines. Converted to pyridoxal-5-phosphate (PLP), an essential cofactor for over 140 enzymatic reactions including synthesis of neurotransmitters (GABA, serotonin, dopamine) and heme synthesis. Indicated for prevention and treatment of drug-induced peripheral neuropathy (from isoniazid, cycloserine, penicillamine), pyridoxine-dependent seizures in infants, idiopathic morning sickness, and sideroblastic anemia.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Doxylamine Succinate and Pyridoxine Hydrochloride Tablets (10mg/10mg, 20mg/20mg) is the first-line evidence-based pharmacotherapy recommended by ACOG and RCOG for nausea and vomiting of pregnancy (NVP / morning sickness) and hyperemesis gravidarum. Doxylamine is an ethanolamine-derivative H1-antihistamine that competitively blocks H1 and muscarinic receptors in the vestibular system and vomiting center; Pyridoxine (Vitamin B6) acts as a coenzyme in neurotransmitter synthesis, improving metabolic pathways disrupted during early pregnancy.

Pyridoxine Hydrochloride Tablets (50mg, 100mg, 100mg Sustained Release) is an oral Vitamin B6 formulation on the WHO Model List of Essential Medicines. Converted to pyridoxal-5-phosphate (PLP), an essential cofactor for over 140 enzymatic reactions including synthesis of neurotransmitters (GABA, serotonin, dopamine) and heme synthesis. Indicated for prevention and treatment of drug-induced peripheral neuropathy (from isoniazid, cycloserine, penicillamine), pyridoxine-dependent seizures in infants, idiopathic morning sickness, and sideroblastic anemia.

Pyridoxine Hydrochloride Tablets (50mg, 100mg, 100mg Sustained Release) is an oral Vitamin B6 formulation on the WHO Model List of Essential Medicines. Converted to pyridoxal-5-phosphate (PLP), an essential cofactor for over 140 enzymatic reactions including synthesis of neurotransmitters (GABA, serotonin, dopamine) and heme synthesis. Indicated for prevention and treatment of drug-induced peripheral neuropathy (from isoniazid, cycloserine, penicillamine), pyridoxine-dependent seizures in infants, idiopathic morning sickness, and sideroblastic anemia.

Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.

Vitamin B-Complex Formulations (Tablets, Capsules with Zinc, Syrup, and Injection) is a balanced formulation of essential B-group vitamins (B1 Thiamine, B2 Riboflavin, B3 Niacinamide, B5 Calcium Pantothenate, B6 Pyridoxine, B9 Folic Acid, B12 Cobalamin) on the WHO Model List of Essential Medicines. B-vitamins act as critical water-soluble coenzymes in cellular Krebs cycle energy production, carbohydrate and lipid metabolism, erythropoiesis, and myelin integrity. Indicated for prevention and treatment of generalized B-complex deficiencies, aphthous stomatitis/glossitis/angular cheilitis, convalescence, chronic debilitating illness, and nutritional maintenance during prolonged antibiotic therapy.

Potassium Citrate (1100mg) and Magnesium Citrate (375mg, with or without Pyridoxine 20mg or Citric Acid 334mg per 5ml) Oral Solution is a specialized dual-mineral nephrolithiasis inhibitor on the PMBI formulary. Absorbed citrate is metabolized to bicarbonate, alkalinizing the urine and increasing urinary citrate excretion. Citrate forms soluble chelates with calcium, preventing calcium oxalate and calcium phosphate crystal nucleation and agglomeration. Magnesium competes with calcium to form highly soluble magnesium oxalate, further retarding stone growth. Pyridoxine (vitamin B6) acts as a cofactor for alanine:glyoxylate aminotransferase, reducing endogenous oxalate production. Indicated for renal tubular acidosis (RTA) with calcium stones, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis.

Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcium Formulations (Calcium Carbonate 500mg/1250mg, Calcium Citrate Malate 250mg/1000mg, Coral Calcium with Vitamin D3 250-2000 IU, Vitamin K2-7, Magnesium, and Zinc) is an oral bone remineralization complex on the WHO Model List of Essential Medicines. Calcium provides elemental bone mineral matrix; vitamin D3 stimulates intestinal calcium transport; vitamin K2-7 (menaquinone-7) activates osteocalcin to bind calcium into hydroxyapatite crystals while preventing ectopic arterial vascular calcification; zinc and magnesium act as essential osteoblast cofactors. Indicated for prevention and treatment of postmenopausal osteoporosis, osteopenia, pregnancy/lactation calcium demands, and bone fracture healing.

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Pyridoxine Hydrochloride Tablets (50mg, 100mg, 100mg Sustained Release) is an oral Vitamin B6 formulation on the WHO Model List of Essential Medicines. Converted to pyridoxal-5-phosphate (PLP), an essential cofactor for over 140 enzymatic reactions including synthesis of neurotransmitters (GABA, serotonin, dopamine) and heme synthesis. Indicated for prevention and treatment of drug-induced peripheral neuropathy (from isoniazid, cycloserine, penicillamine), pyridoxine-dependent seizures in infants, idiopathic morning sickness, and sideroblastic anemia.